Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

[Efficacy of conventional chemotherapy in a primary double-refractory IgM multiple myeloma.]

Innao V, Allegra A, Allegra AG, Musolino C.

Recenti Prog Med. 2019 Jul-Aug;110(7):364-367. doi: 10.1701/3197.31749. Italian.

PMID:
31379372
2.

Mitochondria-Targeted Antioxidant SkQ1 for Gammopathy-Related Corneal Damage.

Innao V, Allegra A, Musolino C.

Am J Ther. 2019 Jul 3. doi: 10.1097/MJT.0000000000001010. [Epub ahead of print] No abstract available.

PMID:
31356345
3.

Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinoma.

Pollicino T, Musolino C, Saitta C, Tripodi G, Lanza M, Raffa G, Tocco FCD, Raggi C, Bragazzi MC, Barbera A, Navarra G, Invernizzi P, Alvaro D, Raimondo G.

Oncotarget. 2019 Jun 11;10(39):3931-3938. doi: 10.18632/oncotarget.27002. eCollection 2019 Jun 11.

4.

Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs.

Montefusco V, Gay F, Spada S, De Paoli L, Di Raimondo F, Ribolla R, Musolino C, Patriarca F, Musto P, Galieni P, Ballanti S, Nozzoli C, Cascavilla N, Ben-Yehuda D, Nagler A, Hajek R, Offidani M, Liberati AM, Sonneveld P, Cavo M, Corradini P, Boccadoro M.

Haematologica. 2019 Jun 20. pii: haematol.2019.219139. doi: 10.3324/haematol.2019.219139. [Epub ahead of print]

5.

Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma.

Allegra A, Innao V, Allegra AG, Pugliese M, Di Salvo E, Ventura-Spagnolo E, Musolino C, Gangemi S.

Int J Mol Sci. 2019 Jun 10;20(11). pii: E2822. doi: 10.3390/ijms20112822. Review.

6.

Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw.

Allegra A, Innao V, Pulvirenti N, Musolino C.

Tohoku J Exp Med. 2019 May;248(1):27-29. doi: 10.1620/tjem.248.27.

7.

Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib.

Stella S, Zammit V, Vitale SR, Pennisi MS, Massimino M, Tirrò E, Forte S, Spitaleri A, Antolino A, Siracusa S, Accurso V, Mannina D, Impera S, Musolino C, Russo S, Malato A, Mineo G, Musso M, Porretto F, Martino B, Di Raimondo F, Manzella L, Vigneri P, Stagno F.

Int J Mol Sci. 2019 May 6;20(9). pii: E2226. doi: 10.3390/ijms20092226.

8.

Relationship between mitofusin 2 and cancer.

Allegra A, Innao V, Allegra AG, Musolino C.

Adv Protein Chem Struct Biol. 2019;116:209-236. doi: 10.1016/bs.apcsb.2018.11.009. Epub 2018 Dec 27.

PMID:
31036292
9.

Role of the microbiota in hematologic malignancies.

Allegra A, Innao V, Allegra AG, Ettari R, Pugliese M, Pulvirenti N, Musolino C.

Neth J Med. 2019 Feb;77(2):67-80.

10.

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma.

Allegra A, Musolino C, Pace E, Innao V, Di Salvo E, Ferraro M, Casciaro M, Spatari G, Tartarisco G, Allegra AG, Gangemi S.

Antioxidants (Basel). 2019 Mar 4;8(3). pii: E55. doi: 10.3390/antiox8030055.

11.

Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals.

Musolino C, Cacciola I, Tripodi G, Lombardo D, Raffa G, Alibrandi A, Squadrito G, Raimondo G, Pollicino T.

Antivir Ther. 2019;24(3):187-192. doi: 10.3851/IMP3288.

PMID:
30628893
12.

Punching above their weight: a network to understand broader determinants of increasing life expectancy.

Baum F, Popay J, Delany-Crowe T, Freeman T, Musolino C, Alvarez-Dardet C, Ariyaratne V, Baral K, Basinga P, Bassett M, Bishai DM, Chopra M, Friel S, Giugliani E, Hashimoto H, Macinko J, McKee M, Nguyen HT, Schaay N, Solar O, Thiagarajan S, Sanders D.

Int J Equity Health. 2018 Aug 13;17(1):117. doi: 10.1186/s12939-018-0832-y.

13.

NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C.

D'Aliberti D, Cacciola I, Musolino C, Raffa G, Filomia R, Alibrandi A, Benfatto S, Beninati C, Saitta C, Giosa D, Romeo O, Raimondo G, Pollicino T.

Intervirology. 2018;61(1):1-8. doi: 10.1159/000489307. Epub 2018 Jul 18.

PMID:
30021203
14.

The adipose organ and multiple myeloma: Impact of adipokines on tumor growth and potential sites for therapeutic intervention.

Allegra A, Innao V, Gerace D, Allegra AG, Vaddinelli D, Bianco O, Musolino C.

Eur J Intern Med. 2018 Jul;53:12-20. doi: 10.1016/j.ejim.2018.05.033. Epub 2018 May 30. Review.

PMID:
29859797
15.

Positioning relapse and recovery through a cultural lens of desire: A South Australian case study of disordered eating.

Musolino C, Warin M, Gilchrist P.

Transcult Psychiatry. 2018 Aug;55(4):534-550. doi: 10.1177/1363461518778669. Epub 2018 May 31.

PMID:
29848200
16.

Nanobodies and Cancer: Current Status and New Perspectives.

Allegra A, Innao V, Gerace D, Vaddinelli D, Allegra AG, Musolino C.

Cancer Invest. 2018 Apr 21;36(4):221-237. doi: 10.1080/07357907.2018.1458858. Epub 2018 Apr 16. Review.

PMID:
29658806
17.

Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw.

Musolino C, Oteri G, Allegra A, Mania M, D'Ascola A, Avenoso A, Innao V, Allegra AG, Campo S.

Ann Hematol. 2018 Jul;97(7):1259-1269. doi: 10.1007/s00277-018-3296-7. Epub 2018 Mar 15.

PMID:
29546453
18.

Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms.

De Stefano V, Carobbio A, Di Lazzaro V, Guglielmelli P, Iurlo A, Finazzi MC, Rumi E, Cervantes F, Elli EM, Randi ML, Griesshammer M, Palandri F, Bonifacio M, Hernandez-Boluda JC, Cacciola R, Miroslava P, Carli G, Beggiato E, Ellis MH, Musolino C, Gaidano G, Rapezzi D, Tieghi A, Lunghi F, Loscocco GG, Cattaneo D, Cortelezzi A, Betti S, Rossi E, Finazzi G, Censori B, Cazzola M, Bellini M, Arellano-Rodrigo E, Bertozzi I, Sadjadian P, Vianelli N, Scaffidi L, Gomez M, Cacciola E, Vannucchi AM, Barbui T.

Blood Cancer J. 2018 Feb 28;8(3):25. doi: 10.1038/s41408-018-0048-9.

19.

Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-κB pathways.

Allegra A, Speciale A, Molonia MS, Guglielmo L, Musolino C, Ferlazzo G, Costa G, Saija A, Cimino F.

Toxicol In Vitro. 2018 Mar;47:186-194. doi: 10.1016/j.tiv.2017.12.001. Epub 2017 Dec 6.

PMID:
29223572
20.

Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma.

Musolino C, Allegra A, Innao V, Allegra AG, Pioggia G, Gangemi S.

Mediators Inflamm. 2017;2017:1852517. doi: 10.1155/2017/1852517. Epub 2017 Sep 26. Review.

21.

Flavocoxid exerts a potent antiviral effect against hepatitis B virus.

Pollicino T, Musolino C, Irrera N, Bitto A, Lombardo D, Timmoneri M, Minutoli L, Raimondo G, Squadrito G, Squadrito F, Altavilla D.

Inflamm Res. 2018 Jan;67(1):89-103. doi: 10.1007/s00011-017-1099-2. Epub 2017 Oct 10.

PMID:
29018874
22.

High BCR-ABL/GUSIS Levels at Diagnosis of Chronic Phase CML Are Associated with Unfavorable Responses to Standard-Dose Imatinib.

Vigneri P, Stagno F, Stella S, Cupri A, Forte S, Massimino M, Antolino A, Siragusa S, Mannina D, Impera SS, Musolino C, Malato A, Mineo G, Tomaselli C, Murgano P, Musso M, Morabito F, Molica S, Martino B, Manzella L, Müller MC, Hochhaus A, Raimondo FD.

Clin Cancer Res. 2017 Dec 1;23(23):7189-7198. doi: 10.1158/1078-0432.CCR-17-0962. Epub 2017 Sep 19.

23.

Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma.

Ettari R, Zappalà M, Grasso S, Musolino C, Innao V, Allegra A.

Pharmacol Ther. 2018 Feb;182:176-192. doi: 10.1016/j.pharmthera.2017.09.001. Epub 2017 Sep 11. Review.

PMID:
28911826
24.

Spontaneous Healing of Clodronate-Related Osteonecrosis of the Jaw.

Nastro Siniscalchi E, Allegra A, De Ponte FS, Oteri G, Cervino G, Lauritano F, Musolino C, Cicciù M.

J Craniofac Surg. 2017 Oct;28(7):e687-e689. doi: 10.1097/SCS.0000000000003837.

PMID:
28857991
25.

Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant.

Petrungaro A, Gentile M, Mazzone C, Greco R, Uccello G, Recchia AG, De Stefano L, Bossio S, Palummo A, Morelli R, Musolino C, Morabito F, Vigna E.

Chemotherapy. 2017;62(6):353-356. doi: 10.1159/000477714. Epub 2017 Aug 16.

26.

Genetic risk of prediabetes and diabetes development in chronic myeloid leukemia patients treated with nilotinib.

Martino B, Mammì C, Labate C, Rodi S, Ielo D, Priolo M, Postorino M, Tripepi G, Ronco F, Laganà C, Musolino C, Greco M, La Nasa G, Caocci G.

Exp Hematol. 2017 Nov;55:71-75. doi: 10.1016/j.exphem.2017.07.007. Epub 2017 Jul 28.

PMID:
28757432
27.

Disappearance of Bone Marrow Fibrosis in a Patient with Chronic Myeloid Leukemia Treated with Dasatinib.

Vigna E, Martino B, Bacci F, Recchia AG, Mendicino F, Morelli R, Mauro FR, Musolino C, Greco R, Lucia E, Sabattini E, Morabito F, Gentile M.

Chemotherapy. 2017;62(6):350-352. doi: 10.1159/000477796. Epub 2017 Jul 26.

28.

Standardisation of minimal residual disease in multiple myeloma.

Innao V, Allegra A, Russo S, Gerace D, Vaddinelli D, Alonci A, Allegra AG, Musolino C.

Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12732. Epub 2017 Jul 3. Review.

PMID:
28671297
29.

Raman spectroscopy differentiates between sensitive and resistant multiple myeloma cell lines.

Franco D, Trusso S, Fazio E, Allegra A, Musolino C, Speciale A, Cimino F, Saija A, Neri F, Nicolò MS, Guglielmino SPP.

Spectrochim Acta A Mol Biomol Spectrosc. 2017 Dec 5;187:15-22. doi: 10.1016/j.saa.2017.06.020. Epub 2017 Jun 15.

PMID:
28645097
30.

MicroRNA Profiling in Asthma: Potential Biomarkers and Therapeutic Targets.

Heffler E, Allegra A, Pioggia G, Picardi G, Musolino C, Gangemi S.

Am J Respir Cell Mol Biol. 2017 Dec;57(6):642-650. doi: 10.1165/rcmb.2016-0231TR.

PMID:
28489455
31.

Vertical Gastric Bypass with Fundectomy: Feasibility and 2-Year Follow-Up in a Series of Morbidly Obese Patients.

Zappa MA, Aiolfi A, Musolino C, Giusti MP, Lesti G, Porta A.

Obes Surg. 2017 Aug;27(8):2145-2150. doi: 10.1007/s11695-017-2620-y.

PMID:
28271378
32.

How gene polymorphisms can influence clinical response and toxicity following R-CHOP therapy in patients with diffuse large B cell lymphoma.

Falduto A, Cimino F, Speciale A, Musolino C, Gangemi S, Saija A, Allegra A.

Blood Rev. 2017 Jul;31(4):235-249. doi: 10.1016/j.blre.2017.02.005. Epub 2017 Feb 27. Review.

PMID:
28262268
33.

Telomerase and telomere biology in hematological diseases: A new therapeutic target.

Allegra A, Innao V, Penna G, Gerace D, Allegra AG, Musolino C.

Leuk Res. 2017 May;56:60-74. doi: 10.1016/j.leukres.2017.02.002. Epub 2017 Feb 7. Review.

PMID:
28196338
34.

Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient.

Innao V, Allegra A, Morreale R, Russo S, Musolino C.

Turk J Haematol. 2017 Jun 5;34(2):184-185. doi: 10.4274/tjh.2016.0146. Epub 2017 Jan 12. No abstract available.

35.

Developing shared understandings of recovery and care: a qualitative study of women with eating disorders who resist therapeutic care.

Musolino C, Warin M, Wade T, Gilchrist P.

J Eat Disord. 2016 Dec 16;4:36. doi: 10.1186/s40337-016-0114-2. eCollection 2016.

36.

Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies.

Allegra A, Innao V, Russo S, Gerace D, Alonci A, Musolino C.

Cancer Invest. 2017 Jan 2;35(1):1-22. doi: 10.1080/07357907.2016.1247166. Epub 2016 Dec 20. Review.

PMID:
27996308
37.

Immature myeloid-derived suppressor cells: A bridge between inflammation and cancer (Review).

Musolino C, Allegra A, Pioggia G, Gangemi S.

Oncol Rep. 2017 Feb;37(2):671-683. doi: 10.3892/or.2016.5291. Epub 2016 Dec 5. Review.

PMID:
27922687
38.

Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells.

Allegra A, Innao V, Gerace D, Vaddinelli D, Musolino C.

Blood Cells Mol Dis. 2016 Nov;62:49-63. doi: 10.1016/j.bcmd.2016.11.001. Epub 2016 Nov 10. Review.

PMID:
27865176
39.

Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients.

De Stefano V, Vannucchi AM, Ruggeri M, Cervantes F, Alvarez-Larrán A, Iurlo A, Randi ML, Pieri L, Rossi E, Guglielmelli P, Betti S, Elli E, Finazzi MC, Finazzi G, Zetterberg E, Vianelli N, Gaidano G, Nichele I, Cattaneo D, Palova M, Ellis MH, Cacciola E, Tieghi A, Hernandez-Boluda JC, Pungolino E, Specchia G, Rapezzi D, Forcina A, Musolino C, Carobbio A, Griesshammer M, Barbui T.

Blood Cancer J. 2016 Nov 4;6(11):e493. doi: 10.1038/bcj.2016.103.

40.

A population-based study of chronic myeloid leukemia patients treated with imatinib in first line.

Castagnetti F, Di Raimondo F, De Vivo A, Spitaleri A, Gugliotta G, Fabbiano F, Capodanno I, Mannina D, Salvucci M, Antolino A, Marasca R, Musso M, Crugnola M, Impera S, Trabacchi E, Musolino C, Cavazzini F, Mineo G, Tosi P, Tomaselli C, Rizzo M, Siragusa S, Fogli M, Ragionieri R, Zironi A, Soverini S, Martinelli G, Cavo M, Vigneri P, Stagno F, Rosti G, Baccarani M.

Am J Hematol. 2017 Jan;92(1):82-87. doi: 10.1002/ajh.24591. Epub 2016 Nov 18.

41.

The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.

Molica S, Shanafelt TD, Giannarelli D, Gentile M, Mirabelli R, Cutrona G, Levato L, Di Renzo N, Di Raimondo F, Musolino C, Angrilli F, Famà A, Recchia AG, Chaffee KG, Neri A, Kay NE, Ferrarini M, Morabito F.

Am J Hematol. 2016 Nov;91(11):1090-1095. doi: 10.1002/ajh.24493. Epub 2016 Aug 8.

42.

Prospective Comparison and Quality of Life for Single-Incision and Conventional Laparoscopic Sleeve Gastrectomy in a Series of Morbidly Obese Patients.

Porta A, Aiolfi A, Musolino C, Antonini I, Zappa MA.

Obes Surg. 2017 Mar;27(3):681-687. doi: 10.1007/s11695-016-2338-2.

PMID:
27686234
43.

lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome.

Ronchetti D, Manzoni M, Agnelli L, Vinci C, Fabris S, Cutrona G, Matis S, Colombo M, Galletti S, Taiana E, Recchia AG, Bossio S, Gentile M, Musolino C, Di Raimondo F, Grilli A, Bicciato S, Cortelezzi A, Tassone P, Morabito F, Ferrarini M, Neri A.

Blood Cancer J. 2016 Sep 9;6(9):e468. doi: 10.1038/bcj.2016.77.

44.

The metabolomic signature of hematologic malignancies.

Allegra A, Innao V, Gerace D, Bianco O, Musolino C.

Leuk Res. 2016 Oct;49:22-35. doi: 10.1016/j.leukres.2016.08.002. Epub 2016 Aug 8. Review.

PMID:
27526405
45.

Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal Gammopathies.

Aragona P, Allegra A, Postorino EI, Rania L, Innao V, Wylegala E, Nowinska A, Ieni A, Pisani A, Musolino C, Puzzolo D, Micali A.

Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2657-65. doi: 10.1167/iovs.15-18594.

PMID:
27177322
46.

Subcapsular hepatic haematoma of the right lobe following endoscopic retrograde cholangiopancreatography: Case report and literature review.

Zappa MA, Aiolfi A, Antonini I, Musolino CD, Porta A.

World J Gastroenterol. 2016 May 7;22(17):4411-5. doi: 10.3748/wjg.v22.i17.4411. Review.

47.

High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists.

De Stefano V, Ruggeri M, Cervantes F, Alvarez-Larrán A, Iurlo A, Randi ML, Elli E, Finazzi MC, Finazzi G, Zetterberg E, Vianelli N, Gaidano G, Rossi E, Betti S, Nichele I, Cattaneo D, Palova M, Ellis MH, Cacciola R, Tieghi A, Hernandez-Boluda JC, Pungolino E, Specchia G, Rapezzi D, Forcina A, Musolino C, Carobbio A, Griesshammer M, Sant'Antonio E, Vannucchi AM, Barbui T.

Leukemia. 2016 Oct;30(10):2032-2038. doi: 10.1038/leu.2016.85. Epub 2016 Apr 26.

PMID:
27113812
48.

Extramedullary Plasmacytoma of the Maxilla Simulating a Maxillary Radicular Cyst: Quick Diagnosis and Management.

Allegra A, Nastro Siniscalchi E, Cicciù M, Bacci F, Catalfamo L, Innao V, De Ponte FS, Musolino C.

J Craniofac Surg. 2016 May;27(3):e296-7. doi: 10.1097/SCS.0000000000002539.

PMID:
27054435
49.

Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia.

Gugliotta G, Castagnetti F, Breccia M, Gozzini A, Usala E, Carella AM, Rege-Cambrin G, Martino B, Abruzzese E, Albano F, Stagno F, Luciano L, D'Adda M, Bocchia M, Cavazzini F, Tiribelli M, Lunghi M, Pia Falcone A, Musolino C, Levato L, Venturi C, Soverini S, Cavo M, Alimena G, Pane F, Martinelli G, Saglio G, Rosti G, Baccarani M; GIMEMA CML Working Party.

Am J Hematol. 2016 Jun;91(6):617-22. doi: 10.1002/ajh.24362. Epub 2016 Apr 24.

50.

Splenic rupture following colonoscopy: Case report and literature review.

Zappa MA, Aiolfi A, Antonini I, Musolino CD, Porta A.

Int J Surg Case Rep. 2016;21:118-20. doi: 10.1016/j.ijscr.2016.02.038. Epub 2016 Mar 4.

Supplemental Content

Loading ...
Support Center